These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7662682)

  • 1. The contraceptive use of Depo-Provera in U.S. adolescents.
    Pinkston Koenigs LM; Miller NH
    J Adolesc Health; 1995 May; 16(5):347-9. PubMed ID: 7662682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.
    Paschall S; Kaunitz AM
    Contraception; 2008 Nov; 78(5):370-6. PubMed ID: 18929733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A
    Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC
    Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of depot medroxyprogesterone acetate contraception in adolescents.
    Davis AJ
    J Reprod Med; 1996 May; 41(5 Suppl):407-13. PubMed ID: 8725703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR; Hammond N; Brown HE; Roddy ME
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of depo-provera in teens.
    Khoiny FE
    J Pediatr Health Care; 1996; 10(5):195-201. PubMed ID: 8920351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicolegal issues surrounding Depo-Provera easily overcome.
    Contracept Technol Update; 1992 Jan; 13(1):16, 18. PubMed ID: 12343460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent knowledge and use of injectable contraceptives in developing countries.
    Singh S
    J Adolesc Health; 1995 May; 16(5):396-404. PubMed ID: 7662691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depo-Provera -- proving its innocence.
    Choudhury IR
    Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Norplant and Depo Provera in adolescents.
    Ammerman SD
    J Adolesc Health; 1995 May; 16(5):343-6. PubMed ID: 7662681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.